Skip to main content
. Author manuscript; available in PMC: 2015 Sep 29.
Published in final edited form as: J Urol. 2014 May 21;192(5):1390–1396. doi: 10.1016/j.juro.2014.05.088

Table 2.

Outcomes by PSA group

UD LD-Stable LD-Unstable Overall
No. pts 419 93 54 566
No. BCR events (%) 27 (6) 7 (7) 37 (68) 71 (12)
No. BCR surgery type:
  ORP 26 5 15 46
  RARP 1 2 22 25
No. XRT for PSA less than 0.2 ng/ml 2 2 7 11
No. XRT 13 4 24 41
No. ADT 4 1 2 7
No. XRT/ADT 1 0 1 2
No. metastasis 3 0 1 4
No. death 36 0 2 38
No. prostate Ca death 1 0 0 1
Median followup (mos) 85 69 84
Median followup to PSA greater than 0.2 ng/ml (mos) 84 96 51
% 7-yr BCR-free survival 95.1 94.5 37.3